LIR-6 Polyclonal Antibody

Rabbit Anti-LIR-6 Polyclonal Antibody

Product Specifications

Background

LILRA1 encodes an activating member of the leukocyte immunoglobulin-like receptor (LIR) family, which is found in a gene cluster at chromosomal region 19q13. Leukocyte immunoglobulin-like receptor subfamily A member 1 is predominantly expressed in B cells, interacts with major histocompatibility complex class I ligands, and contributes to the regulation of immune responses. Alternative splicing results in multiple transcript variants encoding different isoforms.

CAS Number

9007-83-4

Product Name Alternative

LILRA1; LIR6; Leukocyte immunoglobulin-like receptor subfamily A member 1; CD85 antigen-like family member I; Leukocyte immunoglobulin-like receptor 6; LIR-6; CD antigen CD85i

Gene ID

11024

Accession Number

O75019

Reactivity

Human

Immunogen

Synthesized peptide derived from the Internal region of human LIR-6 at AA range: 30-110

Clonality

Polyclonal

Tag

Leukocyte immunoglobulin-like receptor subfamily A member 1

Applications

WB, IHC

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

53kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

LIR-6 Polyclonal Antibody detects endogenous levels of LIR-6 protein.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000; IHC 1:50-300

Other Product Names

LILRA1; LIR6; Leukocyte immunoglobulin-like receptor subfamily A member 1; CD85 antigen-like family member I; Leukocyte immunoglobulin-like receptor 6; LIR-6; CD antigen CD85i